相似文献
1
The Hippo Signaling Pathway in Development and Disease.
Dev Cell. 2019 Aug 5;50(3):264-282. doi: 10.1016/j.devcel.2019.06.003.
2
ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation.
Nat Commun. 2022 Feb 4;13(1):703. doi: 10.1038/s41467-022-28319-3.
3
The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
Neoplasia. 2008 Nov;10(11):1204-12. doi: 10.1593/neo.08642.
4
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
Genes Dev. 2015 Jun 15;29(12):1271-84. doi: 10.1101/gad.262816.115.
5
Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
Cancer Sci. 2022 Jun;113(6):1900-1908. doi: 10.1111/cas.15352. Epub 2022 Apr 17.
6
KIBRA connects Hippo signaling and cancer.
Exp Cell Res. 2021 Jun 15;403(2):112613. doi: 10.1016/j.yexcr.2021.112613. Epub 2021 Apr 24.
7
RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner.
Mol Hum Reprod. 2019 Feb 1;25(2):43-60. doi: 10.1093/molehr/gay048.
8
The Hippo-YAP signaling pathway and contact inhibition of growth.
J Cell Sci. 2014 Feb 15;127(Pt 4):709-17. doi: 10.1242/jcs.140103.
9
Opposing transcriptional and post-transcriptional roles for Scalloped in binary Hippo-dependent neural fate decisions.
Dev Biol. 2019 Nov 1;455(1):51-59. doi: 10.1016/j.ydbio.2019.06.022. Epub 2019 Jun 29.
10
Regulation of the Hippo Pathway Transcription Factor TEAD.
Trends Biochem Sci. 2017 Nov;42(11):862-872. doi: 10.1016/j.tibs.2017.09.003. Epub 2017 Sep 27.
引用本文的文献
1
Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapy.
Commun Med (Lond). 2025 Aug 29;5(1):378. doi: 10.1038/s43856-025-01102-3.
2
Integrative High-Throughput RNAi Screening Identifies BRSK1, STK32C and STK40 as Novel Activators of YAP/TAZ.
Int J Mol Sci. 2025 Aug 13;26(16):7810. doi: 10.3390/ijms26167810.
3
Hemocytes facilitate interclonal cooperation-induced tumor malignancy by hijacking the innate immune system in Drosophila.
EMBO J. 2025 Aug 22. doi: 10.1038/s44318-025-00547-5.
4
Deciphering the enigma: long noncoding RNAs in disease pathogenesis and therapeutic prospects.
Mol Cell Biochem. 2025 Aug 14. doi: 10.1007/s11010-025-05368-y.
5
Astrocytic YAP prevents the glutamate neurotoxicity by upregulation of EAAT2 expression and promotes the gain of stemness in astrocytes in ischemic stroke mice.
Cell Death Dis. 2025 Jul 30;16(1):577. doi: 10.1038/s41419-025-07806-7.
6
Hippo signaling regulates the nuclear behavior and DNA binding times of YAP and TEAD to control transcription.
Sci Adv. 2025 Jul 25;11(30):eadw4974. doi: 10.1126/sciadv.adw4974.
7
Sensing the Stiffness: Cellular Mechano-Sensing at the Implant Interface.
Cells. 2025 Jul 17;14(14):1101. doi: 10.3390/cells14141101.
8
Noncoding RNAs as mechanistic regulators and therapeutic modulators of YAP/TAZ signaling in colorectal cancer.
Med Oncol. 2025 Jul 21;42(8):357. doi: 10.1007/s12032-025-02934-8.
9
Sustained YAP1 signaling alters the fates of lutein and Müllerian mesenchymal cells in mice.
Reproduction. 2025 Jul 24;170(2). doi: 10.1530/REP-24-0450. Print 2025 Aug 1.
10
Actin Branching Regulates Cell Spreading and Force on Talin, but not Activation of YAP.
bioRxiv. 2025 May 11:2025.05.09.653153. doi: 10.1101/2025.05.09.653153.
本文引用的文献
1
High-Molecular-Weight Hyaluronan Is a Hippo Pathway Ligand Directing Cell Density-Dependent Growth Inhibition via PAR1b.
Dev Cell. 2019 May 20;49(4):590-604.e9. doi: 10.1016/j.devcel.2019.04.018. Epub 2019 May 9.
2
Nerfin-1 represses transcriptional output of Hippo signaling in cell competition.
Elife. 2019 Mar 22;8:e38843. doi: 10.7554/eLife.38843.
3
FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis.
Dev Cell. 2019 Feb 25;48(4):460-474.e9. doi: 10.1016/j.devcel.2018.12.021. Epub 2019 Feb 7.
4
Fat-regulated adaptor protein Dlish binds the growth suppressor Expanded and controls its stability and ubiquitination.
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1319-1324. doi: 10.1073/pnas.1811891116. Epub 2019 Jan 3.
5
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.
Cancer Cell. 2018 Dec 10;34(6):893-905.e8. doi: 10.1016/j.ccell.2018.11.006.
6
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ.
Nature. 2018 Nov;563(7730):265-269. doi: 10.1038/s41586-018-0658-1. Epub 2018 Oct 31.
7
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
Cell Rep. 2018 Oct 30;25(5):1304-1317.e5. doi: 10.1016/j.celrep.2018.10.001.
8
RAP2 mediates mechanoresponses of the Hippo pathway.
Nature. 2018 Aug;560(7720):655-660. doi: 10.1038/s41586-018-0444-0. Epub 2018 Aug 22.
9
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.
Nat Commun. 2018 Jul 9;9(1):2372. doi: 10.1038/s41467-018-04590-1.
10
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity.
Cancer Discov. 2018 Aug;8(8):1026-1043. doi: 10.1158/2159-8290.CD-17-1124. Epub 2018 Jun 15.
Zotero 插件